⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for t(9;22)

Every month we try and update this database with for t(9;22) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaNCT03263572
Accelerated Pha...
Acute Lymphobla...
BCR-ABL1 Fusion...
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
Refractory Acut...
t(9;22)
Blinatumomab
Cytarabine
Methotrexate
Ponatinib
18 Years - M.D. Anderson Cancer Center
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.NCT00390793
Acute Lymphobla...
BCR-ABL1 Fusion...
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
t(9;22)
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin
Methotrexate
Prednisone
Vincristine
18 Years - M.D. Anderson Cancer Center
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaNCT03263572
Accelerated Pha...
Acute Lymphobla...
BCR-ABL1 Fusion...
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
Refractory Acut...
t(9;22)
Blinatumomab
Cytarabine
Methotrexate
Ponatinib
18 Years - M.D. Anderson Cancer Center
Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous LeukemiaNCT03576547
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
Recurrent Chron...
Refractory Acut...
Refractory Chro...
t(9;22)
Dexamethasone
Ponatinib Hydro...
Rituximab
Venetoclax
18 Years - M.D. Anderson Cancer Center
Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous LeukemiaNCT03576547
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
Recurrent Chron...
Refractory Acut...
Refractory Chro...
t(9;22)
Dexamethasone
Ponatinib Hydro...
Rituximab
Venetoclax
18 Years - M.D. Anderson Cancer Center
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.NCT00390793
Acute Lymphobla...
BCR-ABL1 Fusion...
Blast Phase Chr...
Philadelphia Ch...
Recurrent Acute...
t(9;22)
Cyclophosphamid...
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin
Methotrexate
Prednisone
Vincristine
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: